Bg pattern

TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

PACKAGE LEAFLET: INFORMATION FOR THE USER

Troxerutina KERN PHARMA 100 mg/ml oral solution EFG

Read the package leaflet carefully before starting to take the medicine.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you. Do not pass it on to others, even if their symptoms are the same as yours. It may harm them.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet.

Contents of the package leaflet:

  1. What is Troxerutina Kern Pharma and what is it used for
  2. Before taking Troxerutina Kern Pharma
  3. How to take Troxerutina Kern Pharma
  4. Possible side effects of Troxerutina Kern Pharma
  5. Storage of Troxerutina Kern Pharma
  6. Further information

1. What is TROXERUTINA KERN PHARMA and what is it used for

Troxerutina Kern Pharma belongs to the group of capillary protective medicines.

It is indicated for short-term relief (for two to three months) of edema and symptoms related to chronic venous insufficiency (pain, heaviness of legs, swelling, etc.).

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. BEFORE TAKING TROXERUTINA KERN PHARMA

Do not take Troxerutina Kern Pharma

  • if you are allergic (hypersensitive) to troxerutina or any of the other ingredients of Troxerutina Kern Pharma.

Take special care with Troxerutina Kern Pharma

  • if you have or have had gastric or duodenal ulcers, severe bleeding, or a decrease in the number of platelets (blood cells involved in blood coagulation processes).

Use of other medicines

Tell your doctor if you are using or have recently used any other medicines, including those obtained without a prescription.

No interactions with food or other medicines are known. In any case, never use another medicine on your own initiative without your doctor's recommendation.

Pregnancy and breastfeeding

Consult your doctor or pharmacist before using a medicine.

There is no suitable experience regarding the safety of Troxerutina Kern Pharma in pregnancy. Its use in pregnant women will always be done weighing the benefit against the possible risk of administration.

Troxerutina does not pass into breast milk in significant amounts. No harmful effects have been described for the breastfed child.

Driving and using machines

It is unlikely that this medicine will negatively affect your ability to drive vehicles or use hazardous machinery.

Important information about some of the ingredients of Troxerutina Kern Pharma

It may cause allergic reactions (possibly delayed) because it contains methyl parahydroxybenzoate and propyl parahydroxybenzoate.

3. HOW TO TAKE TROXERUTINA KERN PHARMA

Follow the administration instructions of Troxerutina Kern Pharma exactly as indicated by your doctor.

Oral use only.

Adults:

The usual dose is 10 milliliters per day, in one 10 ml dose or two 5 ml doses.

This medicine can be taken mixed with a little cold milk with or without sugar, fruit juice or soda, or sugared water.

If you take more Troxerutina Kern Pharma than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, telephone 91 562 04 20, indicating the medicine and the amount ingested.

If you forget to take Troxerutina Kern Pharma

Do not take a double dose to make up for forgotten doses.

If you have any further questions about the use of this product, ask your doctor or pharmacist.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, Troxerutina Kern Pharma can cause side effects, although not everyone gets them.

The side effects of this medicine are, in general, infrequent, mild, and transient. The most characteristic side effects are digestive disorders, such as dyspepsia (heavy digestion, heartburn, and acidity), nausea, abdominal discomfort, headache, and skin rashes.

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet.

5. Storage of TROXERUTINA KERN PHARMA

Keep out of the reach and sight of children.

No special storage conditions are required.

Do not use Troxerutina Kern Pharma after the expiration date stated on the packaging after Exp. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines in the pharmacy's SIGRE point. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. FURTHER INFORMATION

Composition of Troxerutina Kern Pharma

  • The active ingredient is troxerutina. Each milliliter of the solution contains 100 mg of Troxerutina.
  • The other ingredients are: propylene glycol, methyl parahydroxybenzoate (E-218), propyl parahydroxybenzoate (E-216), potassium sorbate, sodium saccharin, lemon flavor, lime flavor, and purified water.

Appearance of the product and packaging contents

Troxerutina Kern Pharma is an oral solution and is presented in a 200 ml amber glass bottle with a dosing cup.

Marketing authorization holder and manufacturer

KERN PHARMA, S.L.

Polígono Ind. Colón II

Venus, 72

08228 Terrassa (Barcelona)

This package leaflet was approved in May 2009.

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.

Online doctors for TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION

Discuss questions about TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

0.0 (18)
Doctor

Muhammad Tayyab Altaf

General medicine 3 years exp.

Dr. Muhammad Tayyab Altaf is a primary care physician with extensive international experience, offering online consultations for adults and children. His background includes clinical practice in Policlinico San Matteo Hospital Pavia in Italy, Mount Sinai Hospital in New York, United States and other healthcare settings, allowing him to manage a wide range of acute and chronic medical conditions with confidence and clarity.

His clinical expertise spans multi-system conditions, preventive care and long-term management of chronic diseases. Dr. Altaf combines hands-on experience with a strong research background in both medical and surgical fields, enabling him to provide accurate assessments and structured, evidence-based treatment plans. Patients value his ability to explain diagnoses clearly, outline next steps and support them in making informed healthcare decisions.

Online consultations with Dr. Altaf are suitable for many everyday and acute situations where a timely medical opinion can help determine the safest next steps. He evaluates and treats conditions affecting the cardiovascular, respiratory, gastrointestinal, neurological, haematological and endocrine systems. Common examples include:

  • hypertension and other blood pressure issues
  • ischaemic heart disease and angina
  • asthma, COPD and emphysema
  • pneumonia and lung fibrosis
  • gastroenteritis and digestive infections
  • liver conditions, including alcohol-related disease
  • epilepsy, seizures and post-stroke symptoms
  • dementia and cognitive decline
  • anaemia and other haematological changes
  • diabetes, thyroid disorders and pituitary disease
Many patients reach out when they experience new or worsening symptoms, fluctuations in blood pressure, non-severe chest discomfort, breathing symptoms, digestive issues, suspected infections, chronic fatigue or concerns that affect daily life. He also helps patients understand test results, adjust existing treatment plans and navigate long-term health strategies safely and effectively.

When clinically appropriate, Dr. Altaf can also provide health and fitness certificates, including documentation required for physical activity, sports participation or gym use, based on the patient’s health status and medical indications.

Some conditions are not suitable for online care. Severe chest pain, loss of consciousness, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack require immediate attention from local emergency services. Dr. Altaf prioritises patient safety and will guide you accordingly if your situation needs urgent in-person care.

In all consultations, Dr. Muhammad Tayyab Altaf focuses on clear communication, accurate diagnosis and patient-centred decision-making. His approach ensures that individuals and families feel informed, supported and confident in their next steps, no matter where they are.

Camera Book a video appointment
€50

Frequently Asked Questions

Is a prescription required for TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION?
TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION?
The active ingredient in TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION is troxerutin. This information helps identify medicines with the same composition but different brand names.
Who manufactures TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION?
TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION is manufactured by Kern Pharma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to TROXERUTINE KERN PHARMA 100 mg/ml ORAL SOLUTION?
Other medicines with the same active substance (troxerutin) include ESBERIVEN 100 mg/ml ORAL SOLUTION, VARILIV TROXERUTINE 1 g ORAL SOLUTION GRANULES, VENORUTON OXERUTINES 1 g ORAL SOLUTION POWDER. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media